BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18327579)

  • 1. Combination of two fiber-mutant adenovirus vectors, one encoding the chemokine FKN and another encoding cytokine interleukin 12, elicits notably enhanced anti-tumor responses.
    Gao JQ; Kanagawa N; Xu DH; Han M; Sugita T; Hatanaka Y; Tani Y; Mizuguchi H; Tsutsumi Y; Mayumi T; Okada N; Nakagawa S
    Cancer Immunol Immunother; 2008 Nov; 57(11):1657-64. PubMed ID: 18327579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cotransduction of CCL27 gene can improve the efficacy and safety of IL-12 gene therapy for cancer.
    Gao JQ; Kanagawa N; Motomura Y; Yanagawa T; Sugita T; Hatanaka Y; Tani Y; Mizuguchi H; Tsutsumi Y; Mayumi T; Okada N; Nakagawa S
    Gene Ther; 2007 Mar; 14(6):491-502. PubMed ID: 17203106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of antitumor efficacy and safety of in vivo cytokine gene therapy using RGD fiber-mutant adenovirus vector for preexisting murine melanoma.
    Okada Y; Okada N; Mizuguchi H; Takahashi K; Hayakawa T; Mayumi T; Mizuno N
    Biochim Biophys Acta; 2004 Feb; 1670(3):172-80. PubMed ID: 14980444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressive efficacy through augmentation of tumor-infiltrating immune cells by intratumoral injection of chemokine-expressing adenoviral vector.
    Okada N; Sasaki A; Niwa M; Okada Y; Hatanaka Y; Tani Y; Mizuguchi H; Nakagawa S; Fujita T; Yamamoto A
    Cancer Gene Ther; 2006 Apr; 13(4):393-405. PubMed ID: 16224496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumor responses induced by chemokine CCL19 transfected into an ovarian carcinoma model via fiber-mutant adenovirus vector.
    Gao JQ; Sugita T; Kanagawa N; Iida K; Okada N; Mizuguchi H; Nakayama T; Hayakawa T; Yoshie O; Tsutsumi Y; Mayumi T; Nakagawa S
    Biol Pharm Bull; 2005 Jun; 28(6):1066-70. PubMed ID: 15930746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NK cells are migrated and indispensable in the anti-tumor activity induced by CCL27 gene therapy.
    Gao JQ; Tsuda Y; Han M; Xu DH; Kanagawa N; Hatanaka Y; Tani Y; Mizuguchi H; Tsutsumi Y; Mayumi T; Okada N; Nakagawa S
    Cancer Immunol Immunother; 2009 Feb; 58(2):291-9. PubMed ID: 18629495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single intratumoral injection of a fiber-mutant adenoviral vector encoding interleukin 12 induces remarkable anti-tumor and anti-metastatic activity in mice with Meth-A fibrosarcoma.
    Gao JQ; Sugita T; Kanagawa N; Iida K; Eto Y; Motomura Y; Mizuguchi H; Tsutsumi Y; Hayakawa T; Mayumi T; Nakagawa S
    Biochem Biophys Res Commun; 2005 Mar; 328(4):1043-50. PubMed ID: 15707983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated interleukin-12 gene transfer combined with cytosine deaminase followed by 5-fluorocytosine treatment exerts potent antitumor activity in Renca tumor-bearing mice.
    Hwang KS; Cho WK; Yoo J; Yun HJ; Kim S; Im DS
    BMC Cancer; 2005 May; 5():51. PubMed ID: 15910693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor mechanism of intratumoral injection with IL-12-expressing adenoviral vector against IL-12-unresponsive tumor.
    Kanagawa N; Gao JQ; Motomura Y; Yanagawa T; Mukai Y; Yoshioka Y; Okada N; Nakagawa S
    Biochem Biophys Res Commun; 2008 Aug; 372(4):821-5. PubMed ID: 18519033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy.
    Narvaiza I; Mazzolini G; Barajas M; Duarte M; Zaratiegui M; Qian C; Melero I; Prieto J
    J Immunol; 2000 Mar; 164(6):3112-22. PubMed ID: 10706701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells transduced with gp100 gene by RGD fiber-mutant adenovirus vectors are highly efficacious in generating anti-B16BL6 melanoma immunity in mice.
    Okada N; Masunaga Y; Okada Y; Mizuguchi H; Iiyama S; Mori N; Sasaki A; Nakagawa S; Mayumi T; Hayakawa T; Fujita T; Yamamoto A
    Gene Ther; 2003 Oct; 10(22):1891-902. PubMed ID: 14502218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells.
    Okada N; Saito T; Masunaga Y; Tsukada Y; Nakagawa S; Mizuguchi H; Mori K; Okada Y; Fujita T; Hayakawa T; Mayumi T; Yamamoto A
    Cancer Res; 2001 Nov; 61(21):7913-9. PubMed ID: 11691812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fiber-mutant technique can augment gene transduction efficacy and anti-tumor effects against established murine melanoma by cytokine-gene therapy using adenovirus vectors.
    Okada Y; Okada N; Nakagawa S; Mizuguchi H; Kanehira M; Nishino N; Takahashi K; Mizuno N; Hayakawa T; Mayumi T
    Cancer Lett; 2002 Mar; 177(1):57-63. PubMed ID: 11809531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CC-chemokine ligand 17 gene therapy induces tumor regression through augmentation of tumor-infiltrating immune cells in a murine model of preexisting CT26 colon carcinoma.
    Kanagawa N; Niwa M; Hatanaka Y; Tani Y; Nakagawa S; Fujita T; Yamamoto A; Okada N
    Int J Cancer; 2007 Nov; 121(9):2013-2022. PubMed ID: 17621629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells modified to express fractalkine/CX3CL1 in the treatment of preexisting tumors.
    Nukiwa M; Andarini S; Zaini J; Xin H; Kanehira M; Suzuki T; Fukuhara T; Mizuguchi H; Hayakawa T; Saijo Y; Nukiwa T; Kikuchi T
    Eur J Immunol; 2006 Apr; 36(4):1019-27. PubMed ID: 16525992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effect by interleukin-11 receptor alpha-locus chemokine/CCL27, introduced into tumor cells through a recombinant adenovirus vector.
    Gao JQ; Tsuda Y; Katayama K; Nakayama T; Hatanaka Y; Tani Y; Mizuguchi H; Hayakawa T; Yoshie O; Tsutsumi Y; Mayumi T; Nakagawa S
    Cancer Res; 2003 Aug; 63(15):4420-5. PubMed ID: 12907614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenoviral vectors expressing lymphotactin and interleukin 2 or lymphotactin and interleukin 12 synergize to facilitate tumor regression in murine breast cancer models.
    Emtage PC; Wan Y; Hitt M; Graham FL; Muller WJ; Zlotnik A; Gauldie J
    Hum Gene Ther; 1999 Mar; 10(5):697-709. PubMed ID: 10210138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.
    Lee YS; Kim JH; Choi KJ; Choi IK; Kim H; Cho S; Cho BC; Yun CO
    Clin Cancer Res; 2006 Oct; 12(19):5859-68. PubMed ID: 17020994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced antitumor effect and reduced vector dissemination with fiber-modified adenovirus vectors expressing herpes simplex virus thymidine kinase.
    Mizuguchi H; Hayakawa T
    Cancer Gene Ther; 2002 Mar; 9(3):236-42. PubMed ID: 11896439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional targeting of RGD fiber-mutant adenovirus vectors can improve the safety of suicide gene therapy for murine melanoma.
    Okada Y; Okada N; Mizuguchi H; Hayakawa T; Nakagawa S; Mayumi T
    Cancer Gene Ther; 2005 Jul; 12(7):608-16. PubMed ID: 15746944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.